Clinical Trial Update: Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial exploring the effects of pioglitazone and evogliptin on hepatic fibrosis in patients with chronic hepatitis B and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Fibrosis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Evogliptin (evogliptin)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Seung Up Kim | Conditions: Hepatitis B, Chronic, Fibrosis, Liver | Phase 4 | Status: UNKNOWN